✦ LIBER ✦

Targeted therapies: Tyrosine-kinase inhibitors—new standard for NSCLC therapy

✍ Scribed by Saijo, Nagahiro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular target-based cancer therapy: t

✍ Kenji Tamura; Masahiro Fukuoka 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 187 KB

Receptor tyrosine kinase inhibitors: mol

✍ S. Bavcar; D. J. Argyle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Tyrosine kinases as targets for cancer t

✍ Alexander Levitzki 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Tyrosine Kinases as Targets for Cancer T

✍ Krause, Daniela S.; Van Etten, Richard A. 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 577 KB

Bacterial tyrosine kinases: novel target

✍ Alain J. Cozzone 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 711 KB

Is c-Src Tyrosine Kinase a New Target fo

✍ Peng-Sheng Chen; Tomohiko Ai 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 118 KB